1. Home
  2. BBIO vs CEF Comparison

BBIO vs CEF Comparison

Compare BBIO & CEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • CEF
  • Stock Information
  • Founded
  • BBIO 2015
  • CEF N/A
  • Country
  • BBIO United States
  • CEF
  • Employees
  • BBIO N/A
  • CEF N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • CEF
  • Sector
  • BBIO Health Care
  • CEF
  • Exchange
  • BBIO Nasdaq
  • CEF NYSE
  • Market Cap
  • BBIO 6.7B
  • CEF 5.4B
  • IPO Year
  • BBIO 2019
  • CEF N/A
  • Fundamental
  • Price
  • BBIO $34.25
  • CEF $29.06
  • Analyst Decision
  • BBIO Strong Buy
  • CEF
  • Analyst Count
  • BBIO 12
  • CEF 0
  • Target Price
  • BBIO $57.09
  • CEF N/A
  • AVG Volume (30 Days)
  • BBIO 2.9M
  • CEF N/A
  • Earning Date
  • BBIO 04-29-2025
  • CEF N/A
  • Dividend Yield
  • BBIO N/A
  • CEF N/A
  • EPS Growth
  • BBIO N/A
  • CEF N/A
  • EPS
  • BBIO N/A
  • CEF N/A
  • Revenue
  • BBIO $127,415,000.00
  • CEF N/A
  • Revenue This Year
  • BBIO $89.10
  • CEF N/A
  • Revenue Next Year
  • BBIO $57.07
  • CEF N/A
  • P/E Ratio
  • BBIO N/A
  • CEF N/A
  • Revenue Growth
  • BBIO N/A
  • CEF N/A
  • 52 Week Low
  • BBIO $21.62
  • CEF N/A
  • 52 Week High
  • BBIO $39.54
  • CEF N/A
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 50.58
  • CEF 51.70
  • Support Level
  • BBIO $31.77
  • CEF $28.98
  • Resistance Level
  • BBIO $33.93
  • CEF $29.36
  • Average True Range (ATR)
  • BBIO 1.28
  • CEF 0.28
  • MACD
  • BBIO -0.09
  • CEF 0.00
  • Stochastic Oscillator
  • BBIO 57.14
  • CEF 64.11

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About CEF SPROTT PHYSICAL GOLD AND SILVER TR

Sprott Physical Gold and Silver Trust is a closed end mutual fund trust. The trust invests and holds all of its assets in physical gold and silver bullion and seeks to provide a secure, convenient and exchange-traded investment alternative for investors interested in holding physical bullion without the inconvenience that is typical of direct investment.

Share on Social Networks: